KFDA to caution use of Botulinum injection as wrinkle reduction drug

Published: 2002-09-27 06:57:00

Updated: 2002-09-27 06:57:00

The Korea Food and Drug Administration (KFDA) has recently called on the Korea National Council of Consumer Organization and the Korea Doctors Association to guide the safe use of Botulinum injection in more careful manner in a bid to warn the misleading trend that such drug is quite effective in...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK